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Abstract Bone-anchored hearing aids are well-estab-
lished solutions for treatment of hearing-impaired patients.
However, classical systems with percutaneous abutments
have disadvantages concerning aesthetics, hygiene and
adverse soft tissue reactions. The study aimed to evaluate
surgical, functional and audiological results of a new
Baha Attract system, in which the sound processor is
attached by magnetic force. Twenty patients implanted
with a Baha Attract system were divided into two groups:
A—bilateral mixed and conductive hearing loss, B—sin-
gle-sided deafness, and evaluated during a 6-month follow-
up. Parameters analysed comprised: (1) surgery and wound
healing, (2) postoperative functional results (GBI, APHAB
and BAHU questionnaires), (3) audiological results (free
field speech in noise audiometry in two situations: with
signal from implant side and from contralateral side).
Obtained results revealed: mean time of surgery—44 min,
soft tissue reduction—30 %, bone polishing—20 %, hae-
matoma—10 %. Functional results showed: GBI total
score—29.6 points, APHAB global score mean gain—
23.5 %, BAHU ‘good or very good’ score for: aesthetic—
85 %, hygiene—100 %, ease of placing the processor—
100 %, stability of attraction—75 %. Audiological
results—mean gain for the two analysed situations: 32.9 %
(group A—36.5 %, group B—27.5 %). To conclude, the
data obtained prove the safety and effectiveness of the
Baha Attract system in patients with conductive and
mixed hearing loss as well as in patients with single-sided
deafness. Cosmetic aspects are highly acceptable and the
idea of Attract itself is important for patients with limited
manual dexterity.
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Introduction
Bone-anchored hearing aids (BAHAs) are currently well-
established solutions for the treatment of hearing-impaired
patients with unilateral and bilateral mixed and conductive
hearing loss as well as with single-sided deafness. The first
implantation was reported by Tjellstro¨m and Granstro¨m in
1977 [1] and since then more than 100,000 patients have
been implanted worldwide [2]. The traditional system is
composed of a titanium implant connected with percuta-
neous abutment and a sound processor which is attached to
the abutment. Such a solution enables direct, high-quality
sound transmission from the processor to the bone through
the abutment and implant. However, percutaneous abut-
ment requires lifelong daily hygienic care and there is also
a risk of local skin complications including infections, skin
overgrowth and sometimes even implant loss [3]. Addi-
tionally, the cosmetic effect is not optimal and some
patients who could benefit from the system decline because
The initial data were presented during OSSEO 2015—the Fifth
International Congress on Bone Conduction Hearing and Related
Technologies, 20–23.05.2015, Lake Louise, Canada.
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of the skin-penetrating abutment [4]. Therefore, manufac-
turers developed a bone conduction device which enables
sufficient transmission of the sound with an implanted
magnet instead of a percutaneous abutment. The first sys-
tem, Xomed Audiant, was introduced in the 1980s by
Hough et al., but the maximal output was too low for many
patients and the system was discontinued after few years
[5]. The magnetic Sophono system which was first pre-
sented by Siegert under the name Otomag has been avail-
able since 2006. It is composed of an implant with two
magnets implanted into the temporal bone and a sound
processor which is attached outside of the skin by magnetic
attraction force [6, 7]. However, due to insufficient
amplification it is not indicated in patients with mixed
hearing loss with a bone conduction component greater
than 45 dB. Recently, new active bone conduction systems
with implantable transducers and external sound processors
attached by magnetic force have been introduced. The first
one—Vibrant Bonebridge (Medel)—is commercially
available but it is more expensive and significantly larger
than other bone conduction systems [4], and another sys-
tem BCI is undergoing clinical studies [7].
The system which is going to be studied—Baha Attract
(Cochlear Bone-Anchored Solutions AB, Mo¨lnlycke,
Sweden)—was introduced in 2013. It is composed of the
same implant and sound processor as a traditional (classi-
cal) Baha Connect system, but instead of percutaneous
abutment there are two magnetic discs: one below the skin
connected to the implant and a second external one, to
which the sound processor is attached. Additionally, a pad
of soft material covers the surface of the external magnet
and distributes the pressure to the skin and soft tissue
between magnets.
The aim of this study is to evaluate the surgical, func-
tional and audiological results of the Baha Attract system.
Materials and methods
There are 220 patients who have been implanted since
1992 with the different available systems of bone-anchored
solutions in our department. Out of that group, 20 con-
secutive patients (9.1 %) were implanted with the Baha
Attract (Cochlear Bone-Anchored Solutions AB, Mo¨lnly-
cke, Sweden) between September 2014 and January 2015.
All of those patients were enrolled in this prospective
study. The investigation was approved by the local Ethics
Committee.
Group characteristics
The patients (13 female and seven male, aged 25–67 years
with a mean of 50) had no history of conditions that could
jeopardise osseointegration and wound healing. They were
divided into two groups dependent on type of hearing loss:
Group A—bilateral mixed or conductive hearing loss—
n = 12 (n = 11 bilateral mixed, n = 1 bilateral conduc-
tive), and Group B—single-sided deafness—n = 8 (n = 3
normal hearing in contralateral ear; n = 5 mild hearing
impairment in contralateral ear). The characteristics of the
implanted patients are presented in Table 1. The most
frequent indications for the surgery were chronic otitis
media (open cavity) and otosclerosis after unsuccessful
stapedotomy or restapedotomy.
Surgery and fitting
Surgery was performed in the typical way with a C-shaped
incision in all but the first three cases under local anaes-
thesia. During the 6-month follow-up four ambulatory
visits were performed at 10 days, 4 weeks, 3 and 6 months
postoperatively. The processor was attached 4 (±1) weeks
after surgery. Ten patients received Baha BP110, eight
Baha 4 and two Baha 5 processors.
Evaluated parameters
I Evaluation of surgery and wound healing: The fol-
lowing parameters concerning surgery were anal-
ysed: duration of surgery, soft tissue reduction, bone
polishing, bipolar coagulation use and any surgical
problem or difficulty. The process of healing, cos-
metic effect and the patients’ subjective feelings
concerning cutaneous sensibility, pain and numbness
were also evaluated.
II Functional evaluation: The evaluation was per-
formed 2 months (±1 week) after processor activa-
tion. Patients were asked to complete three
questionnaires: (1) GBI (Glasgow Benefit Inventory)
with additions according to Dutt et al. [8] to evaluate
the change in their quality of life after implantation,
(2) APHAB (Abbreviated Profile of Hearing Aid
Benefit) to evaluate the benefits of the Baha Attract
processor, and (3) BAHU (BAHA Aesthetic,
Hygiene and Use) questionnaire to evaluate the
patients’ subjective feelings (a newly created, not
validated questionnaire, details in Table 5). They
were also asked about their mean daily time of use of
the Baha Attract.
III Audiological evaluation: Free field speech in noise
audiometry was performed with and without the
sound processor 2 months (±1 week) after processor
activation. The Polish monosyllabic word test was
used. The signal was presented at 65 dB sound
pressure level (SPL) from a speaker placed 1 m from
the patient on the implant side (Situation 1) and on
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the contralateral side (Situation 2); white noise was
generated from a speaker located 1 m in front of the
patient at the 55 dB SPL.
Results
Surgery and wound healing
The implantation was performed on the right side in 13
cases and on the left in seven. The mean surgery time (from
local anaesthesia to final dressing) was 44 min (range
30–60). There was a need for soft tissue reduction in 30 %
of patients (n = 6), bone polishing in 20 % (n = 4) and
bipolar coagulation use in all patients. In one case the bone
at the primary implant site was less than 2 mm so second
hole was drilled without the need of any additional skin
incisions. In one case there was bleeding from an emissary
vein, which was closed by a bone wax and the operation
was continued.
Healing was uneventful in 90 % (n = 18) of cases. In
two patients with extensive soft tissue reduction a small
haematoma was observed on the day after surgery which
was successfully treated by suction and compression during
the following days. Mild pain just after surgery was
reported by 60 % (n = 12) of patients, but after 1 month
(second visit) 85 % (n = 17) were free from pain. The
remaining 15 % (n = 3) continued to complain of pain,
with significant, gradual decrease in its intensity. 6 months
after implantation (last visit) no patient had any pain. The
sensitivity of the skin around the implant was normal in
85 % (n = 17) of patients; in two it was reduced even
6 months postoperatively and in one there was some
numbness which gradually disappeared.
Most of the patients chose magnet number 3 (70 %,
n = 14) or 4 (25 %, n = 5). Only one patient chose
magnet number 6. In 85 % (n = 17) of patients there was
no need to change the initial magnet during follow-up; in
two cases it was changed for a weaker magnet (n = 1
because of skin redness, n = 1 because of pain) and in one
it will be changed for a stronger one.
Functional results
Glasgow benefit inventory (GBI)
The results showed significant improvement in health status
after implantation (total score 29.6 points) and were similar
in both groups (group A—28.0 points, group B—31.9
points). In both groups the highest improvement was
observed in the general subscale (total: 40.2 points, group
A—38.2 points, group B—43.2 points) and the worst in the
physical health subscale (total—3.3, group A—4.2 points,
group B—2.1 points). The results of the GBI are presented in
Table 2. The results for the first addition introduced by Dutt
et al. related to success of BAHA according to patients and
their families and friends are presented in Table 3. The
second addition, concerning the change in state of health,
showed a significant improvement—from 50 % before
implantation to 81 % after implantation (p\ 0.001).
Table 1 Characteristics of the groups of patients
Group A (n = 12) Group B (n = 8)
Audiological
indications
Bilateral mixed (n = 11) or conductive (n = 1) hearing loss Single-sided deafness (in some cases also mild conductive,
mixed or sensorineural hearing loss in the contralateral ear)
Hearing loss Implanted ear
–Mean PTAa: 59.1 dB
–Mean bone PTAb: 30.6 dB
Implanted ear
–Mean PTAa: 103.6 dBc
Contralateral ear
–Mean PTAa: 31.6 dB




Atresia of external auditory canal—3 (1 congenital in










a PTA pure-tone average—mean of 500, 1000, 2000 and 3000 Hz
b Bone PTA—bone conduction PTA—mean of 500, 1000, 2000 and 3000 Hz in the bone curve
c In case of complete deafness (no response) calculated as 120 dB HL
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Abbreviated profile of hearing aid benefit (APHAB)
In both groups we have observed significant improvement
in the Global score (mean gain: total—23.5 %, group A—
21.4 %, group B—26.4 %) and in three APHAB subscales:
EC (ease of communication) (mean gain: total—43.4 %,
group A—40.7 %, group B—47.6 %), RV (reverberation)
(mean gain: total—40.8 %, group A—40.2 %, group B—
41.5 %), BN (background noise) (mean gain: total—
41.5 %, group A—38.1 %, group B—46.5 %), and a sig-
nificant deterioration in the AV (aversiveness) subscale
(mean deterioration: total—31.7 %, group A—32.9 %,
group B—29.8 %). The results for the APHAB for all
patients are presented in Fig. 1 and results for groups A and
B are presented in Table 4.
BAHA aesthetic, hygiene and use (BAHU)
All patients found it easy or very easy to place the Baha
Attract system processor on the head and it caused no or
only mild hygiene problems in the operated area. Eighty-
five percent (n = 17) of patients answered that the aes-
thetic effect of the system is very good or good. Only one
man—a completely bald teacher in secondary school—was
not satisfied with the aesthetic effect of the system as the
processor is visible to his students. There were no problems
with the stability of processor attraction on the head in
75 % (n = 15) of cases. However, one woman with mag-
net number 3 complained to have such a problem every day
so the magnet will be changed for a number 4 soon. The
results of BAHU for all patients are presented in Table 5.
The mean daily time of use of the Baha Attract was
9.6 h (range 2–16 h) and it was similar in group A (mean
10 h, range 2–16 h) and group B (mean 9 h, range 5–15 h).
Audiological results
The audiological examination was performed in 17 patients
(ten from group A and seven from group B). In Situation 1
in both groups a significant improvement of speech
understanding in noise was observed (mean gain: total—
50.0 %, group A—53.0 %, group B—45.8 %). In Situation
2 improvement was not so evident (mean gain: total—
15.7 %, group A—20.0 %, group B—9.3 %). The mean
value for both situations was also calculated: the mean gain
in all patients was 32.9 %, in group A—36.5 % and in
group B—27.5 %. The audiological results are presented in
Fig. 2.
Discussion
Devices which use bone conduction have been implanted
with success for many years and percutaneous BAHA
implants are accepted as the gold standard [2]. Their effi-
cacy is well proved but unfortunately they have some
important disadvantages effected by percutaneous abut-
ment. Implantation of a BAHA is generally a safe proce-
dure with a very limited number of serious complications;
however, the number of soft tissue problems around the
abutment (soft tissue overgrowth and abutment side
infection) is frequent [9]. Some changes in the operation
Table 2 Quality of life after
implantation according GBI
(Glasgow Benefit Inventory)
questionnaire in both groups of
patients (SD—standard
deviation)
GBI subscales Group A Group B Group A ? Group B
Mean SD Mean SD Mean SD
Total score 28.0 17.3 31.9 12.9 29.6 15.4
General subscale 38.2 24.2 43.2 17.7 40.2 21.4
Social support 11.1 14.8 16.7 19.9 13.3 16.8
Physical health 4.2 7.5 2.1 5.9 3.3 6.8
Table 3 Patients’ subjective










of Baha to others
with similar
hearing problems
Definitely no 0 0 0 0
Rather no 0 10 % 5 % 0
No change/cannot decide 0 0 5 % 25 %
Rather yes 60 % 55 % 40 % 35 %
Definitely yes 40 % 35 % 50 % 40 %
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technique have been introduced to limit the disadvantages
of percutaneous abutments (soft tissue preservation, pouch
technique) but systems without percutaneous abutment
seem to be the best option for cosmetic and hygienic
concerns and the state of the soft tissue. However, such
magnetic systems can cause different problems like limited
transmission of vibrations through the skin, especially at
high frequencies, and problems with good retention. Proper
construction of systems which allow limitation of pressure
on soft tissue, and development of modern processor
technology which makes it possible to compensate for skin
attenuation by increasing the amplification in affected
frequencies seems to be crucial to prevent these problems
[2, 10].
Surgical results for Baha Attract were previously
reported by Iseri et al. [2, 11] and by Briggs et al. [12]. The
mean surgery time in those studies was very similar to that
reported in this study: 48 min [2], 46 min [11] and 45 min
Fig. 1 The benefits of the
Baha Attract processor
according to APHAB
(Abbreviated Profile of Hearing
Aid Benefit) questionnaire
results; (n = 20; error bars
represent SD standard deviation;




Table 4 Details of APHAB (Abbreviated profile of hearing aid benefit) questionnaire results for both groups of patients (SD—standard
deviation)
APHAB subscale Group A Group B
Without Baha With Baha p Without Baha With Baha p
Mean (%) SD (%) Mean (%) SD (%) Mean (%) SD (%) Mean (%) SD (%)
EC 63.8 22.8 23.1 18.7 \0.005 63.0 25.8 15.4 10.9 \0.02
RV 64.2 20.8 24.0 15.7 \0.005 67.1 20.1 25.6 9.3 \0.001
BN 65.2 16.9 27.1 16.7 \0.001 72.0 18.0 25.5 16.2 \0.02
AV 21.1 10.4 54.0 26.4 \0.005 14.3 15.4 44.1 24.2 \0.05
Global score 53.5 11.4 32.1 11.8 \0.005 54.1 13.4 27.7 10.1 \0.001
EC ease of communication, RV reverberation, BN background noise, AV aversiveness
Table 5 Patients’ subjective
feelings concerning Baha
Attract according BAHU
(BAHA aesthetic, hygiene and










1—very negative 0 0 0 0
2—negative 5 % 0 0 5 %
3—neutral 10 % 0 0 20 %
4—positive 25 % 10 % 10 % 35 %
5—very positive 60 % 90 % 90 % 40 %
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[12]. The operations were performed under general
anaesthesia [2, 12] or under local or general anaesthesia
according to the patient’s preference [11]. In our study
85 % of patients were operated on under local anaesthesia
without any problems and we think that Baha Attract
surgery in most adults can be performed this way. Soft
tissue reduction was performed in five of 16 patients
(31.2 %) [11] and three of 27 were operated on (11.1 %)
[12]. In our group it was performed in six of 20 patients
(30 %), placing our patients within the same range. The
need for bone polishing was reported only in one paper and
was performed in five of 12 (41.6 %) [2] and it was higher
than in our study (four of 20, 20 %). Good healing was
observed in all reported cases to date. Iseri et al. described
one case of haematoma on the first postoperative day which
was successfully treated by aspiration, one case of tem-
porary skin erythema with pain and three cases of pain
around the implant which gradually disappeared after
decreasing implant strength [2, 11]. Briggs et al. described
four cases of mild erythema (three dissolved without
treatment, one dissolved after changing the magnet for a
weaker one), four cases of pain on the implant side (two
resolved without treatment, two were mild and present for
a longer time) and one patient with some discomfort on the
implant side which resolved without treatment [12]. They
observed a lot of numbness at the time of initial fitting
(4 weeks—62.9 %) which then gradually decreased
(3 months—25.9 %), and in the majority of patients there
was no pain or pain was very limited [12]. In their group
most of the patients chose magnet number 5 (17 of 27
patients, 63 %) and more than half of patients required a
change of magnet strength, most of them for a weaker one
[12]. In our group, healing was uneventful in 90 % of cases
and there was no need to change the initial magnet in 85 %,
but our follow-up is relatively short so further observations
of operated area and the need to change the magnet are
necessary.
The GBI results after Baha Attract implantation were
presented and compared to patients with percutaneous
Baha Dermalock by Iseri et al. [11]. In the Baha Attract
group they observed an improvement in total score (40.5
points) and in all subscales: General (47.6 points), Social
Support (28.1 points) and Physical Health (23.9 points).
These outcomes were similar to those for patients
implanted with a Baha Dermalock [11]. The results for
our group also showed improvement in the total score (29.6
points) and all subscales: General (40.2 points), Social
Support (13.3 points) and Physical Health (3.3 points) but
this improvement is slightly smaller than those presented
by Iseri et al. It can be explained by the different popula-
tion examined (Polish vs. Turkish) and by the type and
depth of hearing loss—Iseri et al. described only patients
with bilateral conductive or primarily conductive hearing
loss and our group contains patients mainly with mixed
hearing loss (mean bone pure-tone average 30.6 dB) and
with single-sided deafness. The outcomes for our group are
very similar to results of the Polish population implanted
with percutaneous BAHAs (multicentre national study,
unpublished data) for total score (31.9 points) and all
subscales: General (43.6 points), Social Support (15.4
points) and Physical Health (1.71 points).
The outcomes for APHAB in patients with Baha
Attract were presented by Briggs et al. [12]. They found
statistically significant improvement for the APHAB Glo-
bal score and Reverberation and Background Noise sub-
scales, nonsignificant improvement for the Ease of
Communication subscale, and nonsignificant deterioration
for the Aversiveness subscale. The improvement in the
Global score is 16 %, Background Noise 17 %, Ease of
Communication 12 % and the deterioration in Aversive-
ness 12 %. In our group we have observed an even higher
benefit after implantation in the Global score (23.5 %) and
Ease of Communication (43.4 %), Reverberation (40.8 %)
and Background Noise (41.5 %) subscales, and
Fig. 2 Audiological results—
free field speech in noise
audiometry with and without
Baha Attract (n = 17, error
bars represent SD standard
deviation; *p\ 0.001,
**p\ 0.05)
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deterioration in the Aversiveness subscale (31.7 %). Such a
deterioration in this last subscale which quantifies negative
reactions to environmental sounds is typically observed
with different hearing devices because unwanted sounds
also are amplified [13].
The results for the BAHU scale suggest that the Baha
Attract, in the opinion of most of patients, is very aesthetic,
easy to maintain hygienically, it is easy to place the pro-
cessor on the head and has good stability of attraction.
The mean daily time of use of Baha Attract reported by
Briggs et al. [12] was 7.0 h (range 3.4–15.4 h). It was
longer in patients with conductive hearing loss (mean
7.6 h) than in single-sided deafness (mean 6 h). In our
group the average time of daily use was longer—9.6 h
(range 2–16 h), and it was a little longer in group A (mean
10 h) than in group B (mean 9 h). Such a high mean daily
use of the device may suggest good efficacy and good
wearing comfort in most patients.
Audiological results for Baha Attract were previously
presented by Iseri et al. (patients with bilateral conductive
or primarily conductive hearing loss) [2, 11] and by Briggs
et al. (patients with conductive or mild mixed hearing loss
and with single-sided deafness) [12]. Those studies, how-
ever, did not include patients with mixed hearing loss with
mean a bone conduction threshold worse than 30 dB. Iseri
et al. showed improvement of the free field hearing
threshold from 45 dB without Baha Attract to 37 dB with
Baha Attract, and the free field speech recognition
threshold from 56 dB without Baha Attract to 37 dB with
Baha Attract [2]. In the next paper they compared audi-
ological outcomes between Baha Attract and a percuta-
neous system. This study showed the benefit of both
systems, but the results for the frequency-specific hearing
threshold in free field and speech reception thresholds
showed a better gain for the percutaneous system espe-
cially for speech reception thresholds and in high-fre-
quency hearing thresholds [11]. Similarly, Briggs et al. [12]
presented a statistically significant improvement of pure-
tone average, speech recognition in quiet and speech-to-
noise ratio (SNR) in adaptive sentence test in noise after
Baha Attract implantation. In all these tests the results
were similar to the softband test. In our study significant
improvement of speech understanding in noise was
observed in both groups analysed—the mean gain of the
two analysed situations in group A was 36.5 % and in
group B 27.5 %. The results for group A are similar to
results for the Polish population implanted with percuta-
neous BAHAs and analysed under the same conditions
(multicentre national study, unpublished data) in patients
with bilateral mixed hearing loss (38.3 %) and bilateral
conductive hearing loss (34.7 %), and the results for group
B are even better than in patients with single-sided deaf-
ness implanted with a percutaneous BAHA (16.1 %).
Conclusions
Implantation of the Baha Attract system is an easy, safe
and effective procedure. It can be performed under local
anaesthesia in adults. There are no major surgical problems
or complications and in most patients healing, final cosmetic
effect and wearing comfort are very good. The functional
and audiological results show significant gain after implan-
tation in patients with conductive and mixed hearing loss as
well as those with single-sided deafness. The Baha Attract
is a good alternative to percutaneous systems especially for
patients for whom the aesthetic aspect is important and for
patients with limited manual dexterity.
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